Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
Marcus Maurer(Humboldt-Universität zu Berlin), Baldrich Esther Serra, Alis Burciu(Novartis (Switzerland)), Jonny Peter(University of Cape Town), Avantika Barve(Novartis (United States)), Manmath Patekar(Novartis (Switzerland)), Carla Irani(Saint Joseph University), Simon Francis Thomsen(University of Copenhagen), Heike Röckmann(Utrecht University), Kanokvalai Kulthanan(Siriraj Hospital), Michihiro Hide(Hiroshima City Asa Citizens Hospital), Giorgio Walter Canonica(Humanitas University), Olga Ukhanova(Stavropol State Medical University), Rodney Sinclair(The University of Melbourne), Luís Felipe Ensina(Universidade Federal de São Paulo), Gordon Sussman(AllerGen), Petra Staubach(Johannes Gutenberg University Mainz), F. Bérard(Baylor University Medical Center), Thomas Severin(Novartis (Switzerland)), Dimitrios Rigopoulos(National and Kapodistrian University of Athens), S. Gogate(University of Colorado Colorado Springs), Vineeth Varanasi(Novartis (India)), Kiran Godse(D.Y. Patil University), Ana M. Giménez‐Arnau(Universitat Pompeu Fabra), Eva Hua(Novartis (China)), Sarbjit S. Saini(Johns Hopkins University), Jacek C. Szepietowski(Wroclaw Medical University), Anne Goh Eng Kim, Daria Fomina(Sechenov University), Jonathan A. Bernstein(Bernstein Clinical Research Center), Emil Scosyrev(Novartis (United States)), Tonny Tanus(Kern Medical Center), Young‐Min Ye(Ajou University), Kerstin Letzelter(Novartis (Switzerland)), Agondi Rosana, Arenberger Petr(Johannes Gutenberg University Mainz), Asefi Mohammad, Darshna Modi(Novartis (United States)), Ammoury Alfred, Alonso Miguel Angel Tejedor, A. Ahmed, Ardusso Ledit(National University of Rosario), A.C Aditya Natalia, Ledit Ardusso(National University of Rosario), AS Nandini(Novartis (Switzerland)), Almerigogna Fabio, Badhwar Anil, Jeffrey Leflein, A Robert, Clive Grattan(Guy's Hospital)
Cited by 69
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k